secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medicus Pharma Ltd. (MDCX)
CIK:        0001997296
Form:       8-K
Filed at:   2025-12-01T23:59:59+00:00
Accession:  0001062993-25-017085
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medicus Pharma appoints Carolyn Bonner as CFO; Jim Quinlan resigns for health reasons
--------------------------------------------------------------------------------

- James Quinlan resigned as CFO effective Nov 28, 2025, after medical leave since Sep 12, 2025.
- Carolyn Bonner, previously Acting CFO and President, appointed CFO effective Dec 1, 2025; will continue as President.
- Bonner's amended employment agreement: annual base salary $395,000, bonus targets escalating from 60% to 100% over five years.
- Bonner brings nearly 20 years healthcare/life sciences experience; previously CEO of PCL, Inc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1997296/000106299325017085/0001062993-25-017085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1997296/000106299325017085/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-25-017085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer